Are you a Veteran of the United States Armed Forces?

Please complete a short survey about prostate cancer care for Veterans to help us learn what's working well and what needs improvement in the care Veterans receive.

Veterans prostate cancer care survey Complete the Survey

By boosting innate immunity, researchers eradicate aggressive prostate cancer in mice

Brown Mouse wants Better Boosting in Innate Immunity for Eradicating Aggressive Prostate Cancer

Cabozantinib, a drug already used to treat patients with certain types of thyroid or kidney cancer, was able to eradicate invasive prostate cancers in mice by causing tumor cells to secrete factors that entice neutrophils - the first-responders of the immune system - to infiltrate the tumor, where they triggered an immune response that led to tumor clearance.

Read more.


Source: Medical Xpress

Share